- Home
- TRIB vs CODX Comparison
TRIB vs CODX Comparison
Compare TRIB & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRIB
- CODX
- Stock Information
- Founded
- TRIB 1992
- CODX 2013
- Country
- TRIB Ireland
- CODX United States
- Employees
- TRIB N/A
- CODX N/A
- Industry
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- CODX Medical/Dental Instruments
- Sector
- TRIB Health Care
- CODX Health Care
- Exchange
- TRIB Nasdaq
- CODX Nasdaq
- Market Cap
- TRIB 25.5M
- CODX 22.0M
- IPO Year
- TRIB N/A
- CODX 2017
- Fundamental
- Price
- TRIB $0.53
- CODX $0.35
- Analyst Decision
- TRIB
- CODX Hold
- Analyst Count
- TRIB 0
- CODX 1
- Target Price
- TRIB N/A
- CODX $1.00
- AVG Volume (30 Days)
- TRIB 40.2K
- CODX 249.8K
- Earning Date
- TRIB 05-22-2025
- CODX 05-08-2025
- Dividend Yield
- TRIB N/A
- CODX N/A
- EPS Growth
- TRIB N/A
- CODX N/A
- EPS
- TRIB N/A
- CODX N/A
- Revenue
- TRIB $59,126,000.00
- CODX $3,915,160.00
- Revenue This Year
- TRIB $11.63
- CODX N/A
- Revenue Next Year
- TRIB $10.13
- CODX N/A
- P/E Ratio
- TRIB N/A
- CODX N/A
- Revenue Growth
- TRIB N/A
- CODX N/A
- 52 Week Low
- TRIB $0.48
- CODX $0.28
- 52 Week High
- TRIB $3.55
- CODX $2.23
- Technical
- Relative Strength Index (RSI)
- TRIB 37.41
- CODX 40.48
- Support Level
- TRIB $0.51
- CODX $0.33
- Resistance Level
- TRIB $0.60
- CODX $0.40
- Average True Range (ATR)
- TRIB 0.05
- CODX 0.06
- MACD
- TRIB 0.00
- CODX 0.01
- Stochastic Oscillator
- TRIB 35.35
- CODX 58.61
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.